Retraction Notice to: The E3 SUMO Ligase PIASy Is a Regulator of Cellular Senescence and Apoptosis (The E3 SUMO Ligase PIASy Is a Regulator of Cellular Senescence and Apoptosis (2006) 22(6) (783–794), (S1097276506003315), (10.1016/j.molcel.2006.05.016));The E3 SUMO Ligase PIASy Is a Regulator of Cellular Senescence and Apoptosis

Molecular Cell

Volumn 22, Issue 6, 2006, Pages 783-794

  Bischof, Oliver ^a   Schwamborn, Klaus ^a   Martin, Nadine ^a   Werner, Andreas ^a   Sustmann, Claudio ^b   Grosschedl, Rudolf ^b   Dejean, Anne ^a  

^a INSTITUT PASTEUR   (France)

^b MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

Author keywords

CELLCYCLE; PROTEINS

Indexed keywords

ACTIVATED STAT Y PROTEIN INHIBITOR; LIGASE; PROTEIN P53; RETINOBLASTOMA PROTEIN; SUMO PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; SENESCENCE;

EID: 33745210316     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2020.11.049     Document Type: Erratum

References (53)

1. Almasan A., Yin Y., Kelly R., Lee E., Bradley A., Li W., Bertino J., and Wahl G. Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc. Natl. Acad. Sci. USA 92 (1995) 5436-5440
2. Ayyanathan K., Lechner M.S., Bell P., Maul G.G., Schultz D.C., Yamada Y., Tanaka K., Torigoe K., and Rauscher III F.J. Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: a mammalian cell culture model of gene variegation. Genes Dev. 17 (2003) 1855-1869
3. Bischof O., Kim S.H., Irving J., Beresten S., Ellis N.A., and Campisi J. Regulation and localization of the Bloom syndrome protein in response to DNA damage. J. Cell Biol. 153 (2001) 367-380
4. Bischof O., Nacerddine K., and Dejean A. Human papillomavirus oncoprotein E7 targets the promyelocytic leukemia protein and circumvents cellular senescence via the Rb and p53 tumor suppressor pathways. Mol. Cell. Biol. 25 (2005) 1013-1024
5. Boggio R., and Chiocca S. Gam1 and the SUMO pathway. Cell Cycle 4 (2005) 533-535
6. Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 11 (2001) S27-S31
7. Crook T., Tidy J.A., and Vousden K.H. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 67 (1991) 547-556
8. David G., Neptune M.A., and DePinho R.A. SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities. J. Biol. Chem. 277 (2002) 23658-23663
9. Dimri G.P. What has senescence got to do with cancer?. Cancer Cell 7 (2005) 505-512
10. Dimri G.P., Itahana K., Acosta M., and Campisi J. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor. Mol. Cell. Biol. 20 (2000) 273-285
11. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., and Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 75 (1993) 817-825
12. Everett R.D. DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 20 (2001) 7266-7273
13. Fogal V., Kartasheva N.N., Trigiante G., Llanos S., Yap D., Vousden K.H., and Lu X. ASPP1 and ASPP2 are new transcriptional targets of E2F. Cell Death Differ. 12 (2005) 369-376
14. Frolov M.V., and Dyson N.J. Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J. Cell Sci. 117 (2004) 2173-2181
15. Gostissa M., Hengstermann A., Fogal V., Sandy P., Schwarz S.E., Scheffner M., and Del Sal G. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J. 18 (1999) 6462-6471
16. Hay R.T. SUMO: a history of modification. Mol. Cell 18 (2005) 1-12
17. Hayflick L., and Moorhead P.S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25 (1961) 585-621
18. Helt A.M., and Galloway D.A. Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis 24 (2003) 159-169
19. Hershko T., Chaussepied M., Oren M., and Ginsberg D. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F. Cell Death Differ. 12 (2005) 377-383
20. Hickman E.S., Moroni M.C., and Helin K. The role of p53 and pRB in apoptosis and cancer. Curr. Opin. Genet. Dev. 12 (2002) 60-66
21. Itahana K., Dimri G., and Campisi J. Regulation of cellular senescence by p53. Eur. J. Biochem. 268 (2001) 2784-2791
22. Johnson E.S. Protein modification by SUMO. Annu. Rev. Biochem. 73 (2004) 355-382
23. Kakudo Y., Shibata H., Otsuka K., Kato S., and Ishioka C. Lack of correlation between p53-dependent transcriptional activity and the ability to induce apoptosis among 179 mutant p53s. Cancer Res. 65 (2005) 2108-2114
24. Kehmeier E., Ruhl H., Voland B., Conrad Stoppler M., Androphy E., and Stoppler H. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities. Virology 299 (2002) 72-87
25. Kirsh O., Seeler J.S., Pichler A., Gast A., Muller S., Miska E., Mathieu M., Harel-Bellan A., Kouzarides T., Melchior F., and Dejean A. The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase. EMBO J. 21 (2002) 2682-2691
26. Kumar P.P., Purbey P.K., Ravi D.S., Mitra D., and Galande S. Displacement of SATB1-bound histone deacetylase 1 corepressor by the human immunodeficiency virus type 1 transactivator induces expression of interleukin-2 and its receptor in T cells. Mol. Cell. Biol. 25 (2005) 1620-1633
27. Ledl A., Schmidt D., and Muller S. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor. Oncogene 24 (2005) 3810-3818
28. Liu B., Mink S., Wong K.A., Stein N., Getman C., Dempsey P.W., Wu H., and Shuai K. PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity. Nat. Immunol. 5 (2004) 891-898
29. Lowe S.W., Cepero E., and Evan G. Intrinsic tumour suppression. Nature 432 (2004) 307-315
30. Melchior F., and Hengst L. SUMO-1 and p53. Cell Cycle 1 (2002) 245-249
31. Munger K., Basile J.R., Duensing S., Eichten A., Gonzalez S.L., Grace M., and Zacny V.L. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20 (2001) 7888-7898
32. Narita M., Nunez S., Heard E., Lin A.W., Hearn S.A., Spector D.L., Hannon G.J., and Lowe S.W. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113 (2003) 703-716
33. Nelson V., Davis G.E., and Maxwell S.A. A putative protein inhibitor of activated STAT (PIASy) interacts with p53 and inhibits p53-mediated transactivation but not apoptosis. Apoptosis 6 (2001) 221-234
34. Ohtani K., DeGregori J., and Nevins J.R. Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. USA 92 (1995) 12146-12150
35. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., and Vogelstein B. A model for p53-induced apoptosis. Nature 389 (1997) 300-305
36. Rapp L., and Chen J.J. The papillomavirus E6 proteins. Biochim. Biophys. Acta 1378 (1998) F1-F19
37. Reddel R.R. The role of senescence and immortalization in carcinogenesis. Carcinogenesis 21 (2000) 477-484
38. Robles S.J., and Adami G.R. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene 16 (1998) 1113-1123
39. Roth W., Sustmann C., Kieslinger M., Gilmozzi A., Irmer D., Kremmer E., Turck C., and Grosschedl R. PIASy-deficient mice display modest defects in IFN and Wnt signaling. J. Immunol. 173 (2004) 6189-6199
40. Sachdev S., Bruhn L., Sieber H., Pichler A., Melchior F., and Grosschedl R. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev. 15 (2001) 3088-3103
41. Santti H., Mikkonen L., Anand A., Hirvonen-Santti S., Toppari J., Panhuysen M., Vauti F., Perera M., Corte G., Wurst W., et al. Disruption of the murine PIASx gene results in reduced testis weight. J. Mol. Endocrinol. 34 (2005) 645-654
42. Scheffner M., and Whitaker N.J. Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system. Semin. Cancer Biol. 13 (2003) 59-67
43. Schmidt D., and Muller S. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc. Natl. Acad. Sci. USA 99 (2002) 2872-2877
44. Schmidt D., and Muller S. PIAS/SUMO: new partners in transcriptional regulation. Cell. Mol. Life Sci. 60 (2003) 2561-2574
45. Seeler J.S., and Dejean A. Nuclear and unclear functions of SUMO. Nat. Rev. Mol. Cell Biol. 4 (2003) 690-699
46. Serrano M., and Blasco M.A. Putting the stress on senescence. Curr. Opin. Cell Biol. 13 (2001) 748-753
47. Shuai K., and Liu B. Regulation of gene-activation pathways by PIAS proteins in the immune system. Nat. Rev. Immunol. 5 (2005) 593-605
48. Stein G.H., Drullinger L.F., Soulard A., and Dulic V. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol. Cell. Biol. 19 (1999) 2109-2117
49. Sturm S., Koch M., and White F.A. Genomic organization of the gene for mouse PIASgamma and analysis of its promoter. Gene 266 (2001) 123-130
50. Wolfel T., Hauer M., Schneider J., Serrano M., Wolfel C., Klehmann-Hieb E., De Plaen E., Hankeln T., Meyer zum Buschenfelde K.H., and Beach D. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269 (1995) 1281-1284
51. Wong K.A., Kim R., Christofk H., Gao J., Lawson G., and Wu H. Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life. Mol. Cell. Biol. 24 (2004) 5577-5586
52. Wu X., and Levine A.J. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91 (1994) 3602-3606
53. zur Hausen H. Papillomavirus infections-a major cause of human cancers. Biochim. Biophys. Acta 1288 (1996) F55-F78